RNA Interference Technology Market Intelligence Report - Global Forecast to 2027

RNA Interference Technology Market Intelligence Report - Global Forecast to 2027

The Global RNA Interference Technology Market is projected to reach USD 70,590.22 million by 2027 from USD 23,608.24 million in 2021, at a CAGR 20.02% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas RNA Interference Technology Market size was estimated at USD 9,351.71 million in 2021 and expected to reach USD 10,871.10 million in 2022, at a CAGR 19.55% to reach USD 27,312.49 million by 2027.
• The Asia-Pacific RNA Interference Technology Market size was estimated at USD 5,355.39 million in 2021 and expected to reach USD 6,425.59 million in 2022, at a CAGR 20.80% to reach USD 16,642.24 million by 2027.
• The Europe, Middle East & Africa RNA Interference Technology Market size was estimated at USD 8,901.13 million in 2021 and expected to reach USD 10,474.99 million in 2022, at a CAGR 20.04% to reach USD 26,635.48 million by 2027.

Market Segmentation & Coverage:

The report on rna interference technology identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the rna interference technology to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

• dsRNA
• miRNA
• siRNA

Therapeutics:

• Autoimmune Hepatitis
• Hepatitis B and C
• Neurological Disorders
• Oncology
• Respiratory Disorders

Application:

• Drug Discovery and Development
• Therapeutics

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Arkansas
    • California
    • Florida
    • Illinois
    • Kentucky
    • Minnesota
    • New Jersey
    • New Mexico
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Alnylam Pharmaceuticals, Inc.
• Arcturus Therapeutics Holdings Inc.
• Arrowhead Pharmaceuticals, Inc.
• AstraZeneca PLC
• Atalanta Therapeutics
• Bioneer Corporation
• CureVac N.V.
• Dicerna Pharmaceuticals, Inc.
• Gradalis, Inc.
• Ionis Pharmaceuticals, Inc.
• Merck KGaA
• Nutcracker Therapeutics, Inc.
• Phio Pharmaceuticals Corp.
• Sanofi S.A.
• Silence Therapeutics PLC
• Sirnaomics, Inc.
• Thermo Fisher Scientific Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 23,608.24 million

Estimated Year Value: USD 27,771.70 million

Forecast Year Value: USD 70,590.22 million

CAGR (%): 20.02%.

Please Note: PDF & Excel + Online Access - 1 Year